Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
Insurtech Giant Go Digit Buys Stake in Dr Reddy's for Rs 30 Crore Farhat Nasim27 Feb 2025 7:59 PM ISTWith this latest investment in Dr. Reddy's, Go Digit has expanded its footprint in the healthcare sector.
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Study Semaglutide in Type 2 Diabetes Mellitus Dr. Divya Colin20 Feb 2025 6:00 PM ISTNew Delhi: Responding to the proposal presented by Dr. Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
Sun Pharma to pay Rs 160.2 crore penalty, tops list of 6 drug majors facing tax scrutiny Farhat Nasim7 Feb 2025 7:31 PM ISTNew Delhi: Six leading pharmaceutical companies, Sun Pharmaceutical Industries, Ipca Laboratories, Indoco Remedies, Aurobindo Pharma, Lupin Limited,...
Dr Reddys Gets CDSCO Panel Nod To Manufacture, Market Linaclotide Capsules for Chronic Idiopathic Constipation Dr. Divya Colin3 Feb 2025 5:30 PM ISTNew Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Manufacture, Market Esomeprazole Magnesium Dr. Divya Colin30 Nov 2024 5:30 PM ISTNew Delhi: Reviewing the bioequivalence study report of the gastric drug Esomeprazole Magnesium for delayed release oral suspension 10 mg, the Subject...
Dr Reddys Laboratories gets CDSCO Panel Nod to import, market Tegoprazan for gastrointestinal diseases Susmita Roy28 Nov 2024 6:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert Committee (SEC)...
Dr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment Farhat Nasim23 Nov 2024 1:45 PM ISTThe companies have committed to invest over Rs 5,260 crore, which is expected to create 12,490 job opportunities in the pharma sector
USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility Farhat Nasim20 Nov 2024 1:48 PM ISTNew Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...
Dr Reddy's Hit with Rs 27 Lakh Fine in Mexico Farhat Nasim14 Nov 2024 4:26 PM ISTNew Delhi: Hyderabad-based pharmaceutical giant, Dr Reddy’s Laboratories, has been fined approximately Rs 27 lakh by Mexico’s regulatory body,...
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Study Rebamipide, Sodium Alginate Suspension Dr. Divya Colin19 July 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
